Logos Global Management LP Biomea Fusion, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.0 - $12.03 $600,000 - $2.41 Million	-200,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.39 - $9.03 $229,684 - $472,449	-52,320 Reduced 20.74%	200,000 $892,000
Q4 2021 Feb 14, 2022	SELL	$7.22 - $12.72 $3.25 Million - $5.72 Million	-450,000 Reduced 64.07%	252,320 $1.88 Million
Q3 2021 Nov 15, 2021	SELL	$10.0 - $15.99 $4.6 Million - $7.36 Million	-460,000 Reduced 39.58%	702,320 $8.41 Million
Q2 2021 Aug 16, 2021	BUY	$13.65 - $20.93 $15.9 Million - $24.3 Million	1,162,320 New	1,162,320 $18.1 Million

120

17.9M

978K

286K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $255M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.